Objective: Substance use is common among individuals infected with HIV, yet whether
neurocognitive effects of HIV can be distinguished from more nonspecific effects of drug …

Substance abuse and co-infection with hepatitis C (HCV) are two highly relevant
determinants of neurocognitive and neuroimaging abnormalities associated with HIV …

Controversy exists as to whether effects of HIV infection can be detected in the cognitive
profiles of substance users, with methodological differences in degree of control for …

HIV-associated neurocognitive dysfunction persists in the highly active antiretroviral therapy
(HAART) era and may be exacerbated by comorbidities, including substance use and …

HIV-associated neurocognitive disorders (HANDs) remain common despite combined
antiretroviral therapy (cART). Estimates of the prevalence in virologically suppressed people …

Is human immunodeficiency virus still a terminal condition? Recent advances in treatment
have significantly reduced both mortality and morbidity associated with HIV, but these …

Combined antiretroviral therapy (cART) has greatly reduced the severity of HIV-associated
neurocognitive disorders in people living with HIV (PLWH); however, PLWH are more likely …

Objective: HIV infection and current substance use (SU) are linked to cognitive and
functional deficits, yet findings on their combined effects are mixed. Neurocognitive …

Evidence from animal research, postmortem analyses, and magnetic resonance imaging
(MRI) investigations indicate substantial morphological alteration in brain structure as a …

HIV-associated neurocognitive disorders are frequently observed in people with HIV. We
aimed to evaluate the influence of cognitive reserve on the neuropsychological performance …